UNICA IRIS Institutional Research Information System

PAOLETTI, ANNA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 271.468
NA - Nord America 19.887
AS - Asia 9.081
SA - Sud America 1.409
AF - Africa 197
Continente sconosciuto - Info sul continente non disponibili 32
OC - Oceania 27
Totale 302.101
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 233.902
NL - Olanda 30.581
US - Stati Uniti d'America 19.551
SG - Singapore 3.512
CN - Cina 3.379
UA - Ucraina 2.161
SE - Svezia 1.352
DE - Germania 1.221
BR - Brasile 1.111
FI - Finlandia 762
VN - Vietnam 720
FR - Francia 539
GB - Regno Unito 500
HK - Hong Kong 331
KR - Corea 253
IN - India 194
CA - Canada 193
RU - Federazione Russa 176
BD - Bangladesh 168
AR - Argentina 103
MX - Messico 68
IQ - Iraq 67
JP - Giappone 59
ZA - Sudafrica 52
PK - Pakistan 51
EC - Ecuador 50
PH - Filippine 45
TR - Turchia 44
PL - Polonia 39
ID - Indonesia 38
CO - Colombia 34
EU - Europa 31
VE - Venezuela 31
AT - Austria 30
MA - Marocco 30
BE - Belgio 28
ES - Italia 27
MY - Malesia 26
UZ - Uzbekistan 25
CL - Cile 23
JM - Giamaica 23
SA - Arabia Saudita 23
RO - Romania 22
AU - Australia 21
TN - Tunisia 21
PY - Paraguay 20
KE - Kenya 19
UY - Uruguay 19
IE - Irlanda 18
CH - Svizzera 16
CZ - Repubblica Ceca 16
IL - Israele 16
NP - Nepal 16
EG - Egitto 15
JO - Giordania 15
ET - Etiopia 14
LT - Lituania 13
AZ - Azerbaigian 11
CR - Costa Rica 11
PE - Perù 11
AE - Emirati Arabi Uniti 10
PT - Portogallo 10
DZ - Algeria 9
IR - Iran 9
LB - Libano 9
HN - Honduras 8
KZ - Kazakistan 8
MU - Mauritius 8
SN - Senegal 8
TH - Thailandia 8
BG - Bulgaria 7
BO - Bolivia 7
DO - Repubblica Dominicana 7
GT - Guatemala 7
MD - Moldavia 7
NO - Norvegia 7
AL - Albania 5
AO - Angola 5
DK - Danimarca 5
GR - Grecia 5
KG - Kirghizistan 5
PR - Porto Rico 5
NZ - Nuova Zelanda 4
OM - Oman 4
PS - Palestinian Territory 4
RS - Serbia 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
GE - Georgia 3
HR - Croazia 3
LA - Repubblica Popolare Democratica del Laos 3
LV - Lettonia 3
NG - Nigeria 3
QA - Qatar 3
SY - Repubblica araba siriana 3
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
CY - Cipro 2
GA - Gabon 2
Totale 302.063
Salva come PNG Salva come JPEG
Città #
Cagliari 227.226
Amsterdam 30.533
Uta 4.957
Singapore 1.718
Fairfield 1.715
Ashburn 1.582
San Jose 1.273
Woodbridge 1.242
Chandler 1.196
Jacksonville 1.162
Boardman 1.064
Dallas 932
Wilmington 889
Ann Arbor 858
Houston 785
Seattle 724
Nyköping 690
Cambridge 569
Beijing 495
Helsinki 430
Dearborn 387
Nanjing 375
Hefei 340
Los Angeles 334
Hong Kong 301
Lauterbourg 298
Boston 279
Seoul 230
Ho Chi Minh City 229
Santa Clara 211
Buffalo 182
Council Bluffs 163
The Dalles 163
Milan 158
Hanoi 154
New York 147
Shenyang 116
San Diego 115
Shanghai 108
Nanchang 105
Toronto 103
Tianjin 100
Guangzhou 96
Changsha 78
Hebei 76
Jiaxing 74
Redwood City 74
Rome 72
São Paulo 71
Mountain View 62
Redondo Beach 60
Verona 60
London 58
Chicago 57
Jinan 54
Norwalk 53
Orange 51
Frankfurt am Main 50
Orem 50
Washington 50
Brooklyn 49
Sassari 45
Tokyo 45
Rio de Janeiro 40
Munich 39
Atlanta 38
Dong Ket 34
Ningbo 34
Zhengzhou 33
Auburn Hills 32
Da Nang 32
Nuremberg 31
Warsaw 30
Columbus 29
Belo Horizonte 27
Johannesburg 26
Pune 26
Haiphong 25
Curitiba 24
Tashkent 24
Baghdad 22
Brussels 22
Kunming 22
Phoenix 22
San Francisco 22
Campinas 21
Denver 21
Hải Dương 21
Redmond 21
Taizhou 21
Chennai 20
Saint Petersburg 20
Hangzhou 19
Montreal 18
Guayaquil 17
Kingston 17
Manchester 17
Mexico City 17
Molise 17
Mumbai 17
Totale 286.841
Salva come PNG Salva come JPEG
Nome #
Long-acting reversible contraception (LARC) with the intrauterine system with levonorgestrel (6 mcg/d): observational study on the acceptability, quality of life, and sexuality in Italian women 4.111
Overview of elagolix for the treatment of endometriosis 3.534
Urinary metabolomics of pregnant women at term: a combined GC/MS and NMR approach 3.403
Effect of Estradiol valerate plus dienogest on body composition of healthy women in the menopausal transition: a prospective one-year evaluation 3.399
Systemic therapy for the treatment of endometrial cancer 3.112
Vaginosi batterica: efficacia di un trattamento locale con un gel vaginale a base di una frazione batterica derivata da Propionibacterium acnes 3.048
The stimulation of the vaginal immune system with short-term administration of a vaginal gel containing fraction of Propionibacterium acnes, hyaluronic acid and polycarbophil is efficacious in vaginal infections dependent on disorders in the vaginal ecosystem 2.999
Clinical effect of hormonal replacement therapy with estradiol associated with noretisterone or drospirenone. A prospective randomized placebo controlled study 2.979
Olfactory performance in relation to sex and hormonal profile in humans 2.922
Repeated two cycles of ulipristal acetate treatment improve the quality of life in premenopausal women with heavy menstrual bleeding dependent on uterine myomas, without impairment of bone health 2.922
Prophylaxis of peripartum haemorrhage using recombinant factor VIIa (rfVIIa) in pregnant women with congenital factor VII deficiency: A case report and literature review 2.756
Body composition and psychological improvement in healthy premenopausal women assuming the oral contraceptive containing micronized estradiol (E2) and nomegestrol acetate (NOMAC) 2.746
Research development of a new GnRH antagonist (Elagolix) for the treatment of endometriosis: a review of the literature 2.698
Studio epidemiologico sull’osteoporosi postmenopausale 2.593
Vilaprisan for treating uterine fibroids 2.562
Dismenorrea e endometriosi: una innovativa alternativa alla terapia farmacologica nel controllo del dolore 2.486
Interference of dopamine infusion on gamma-amino butyric acid (GABA)-stimulated prolactin increase 2.463
Reduced serum level of THDOC, an anticonvulsant steroid, in women with perimenstrual catamenial epilepsy 2.445
Inhibitory effect of the dopamine agonist bromocriptine on the postcastration gonadotrophin rise in women 2.428
Critical reappraisal of the clinical effectiveness of different methods of assisted fertilization 2.415
Changes of olfactory sensitivity related to sex and hormonal profile in humans 2.396
Placental biomarkers 2.357
Clinical utility of elagolix as an oral treatment for women with uterine fibroids: A short report on the emerging efficacy data 2.357
Norethisterone enanthate as an injectable contraceptive in puerperal and non-puerperal women 2.314
Radioimmunological determination of apparent free progesterone concentration in plasma samples of pregnant and non-pregnant women 2.301
Studio osservazionale sul contraccettivo ormonale contenente estradiolo valerato e dienogest in formulazione quadrifasica: accettabilità, effetto favorevole sulla composizione corporea e sullo stato psicologico. 2.239
“CG Fem, PI 82, Vitamina E” per la terapia della menopausa: quali vantaggi per la sintomatologia neurovegetativa peri-post menopausale 2.226
Placental growth factor and preterm delivery 2.162
Pharmacologic induction of multiple follicular development improves the success rate of artificial insemination with husband's semen in couples with male-related or unexplained infertility 2.081
Influence of oestradiol and progesterone on pulsatile LH secretion in postmenopausal women 2.080
Pharmacokinetic evaluation of ulipristal acetate for uterine leiomyoma treatment 2.071
Effects of the antidopaminergic drug veralipride on LH and PRL secretion in postmenopausal women 2.056
Unbalanced progesterone and estradiol secretion in catamenial epilepsy 2.051
Resistenza all’insulina nella PCOS e trattamento con inositolo e acido alfa-lipoico 2.041
Risultati di uno studio pilota sull’efficacia del palmitoiletanolamide + transpolidatina in donne con endometriosi 2.039
Prevention of postmenopausal bone loss and endometrial responses during a two year prospective study with transdermal 17 beta-estradiol and oral medroxyprogesterone acetate 2.034
Interaction between veralipride and the endogenous opioid system in the regulation of body temperature in postmenopausal women 2.033
Studio osservazionale sul contraccettivo ormonale a base di E2 1,5 mg/NOMAC 2,5 mg in formulazione monofasica 2.032
Regulation of body temperature in postmenopausal women: interactions between bromocriptine and the endogenous opioid system 2.029
Effects of transdermal 17 beta-estradiol treatment and naloxone infusion on gonadotropin response to gonadotropin-releasing hormone in postmenopausal women 1.993
Maternal perinatal depression, anxiety, fear of birth, and perception of infants’ negative affectivity at three months 1.993
Contraception in chronic kidney disease: a best practice position statement by the kidney and pregnancy group of the Italian Society of Nephrology 1.972
Ultrasonographic soft markers for detection of rectosigmoid deep endometriosis 1.940
Screening e diagnosi del Diabete Gestazionale in Sardegna: risultati a confronto. 1.921
Il bi-test: solo screening di cromosomopatie fetali? 1.907
STUDIO OSSERVAZIONALE SUL CONTRACCETTIVO ORMONALE A BASE DI ESTRADIOLO (E2) 1.5 MG/NOMEGESTROLO (NOMAC) 2.5 MG IN FORMULAZIONE MONOFASICA: ACCETTABILITA', EFFETTO FAVOREVOLE SULLA COMPOSIZIONE CORPOREA E SUI PARAMETRI ANTROPOMETRICI 1.902
Modificazioni dell’umore e del comportamento nel puerperio: quali fattori di rischio? 1.901
SARCOPENIA: DIAGNOSI E PROSPETTIVE TERAPEUTICHE 1.895
Monurelle Biogel® vaginal gel in the treatment of vaginal dryness in postmenopausal women 1.828
Attitudes and perceptions towards vulvar and vaginal atrophy in Italian post-menopausal women: Evidence from the European REVIVE survey 1.820
Adherence with ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen supported by the use of a digital tablet dispenser with or without acoustic alarm: an open-label, randomized, multicenter study 1.811
Menopause and hormone replacement therapy: the 2017 Recommendations of the Italian Menopause Society 1.808
Autoimmunity in gestational diabetes mellitus in Sardinia: a preliminary case-control report 1.776
Psychological effect of the oral contraceptive formulation containing 3 mg of drospirenone plus 30 mu g of ethinyl estradiol 1.768
Fattore di Crescita Placentare (PlGF): correlazioni con la funzione placentare 1.766
Effect of ultramicronized-palmitoylethanolamide and co-micronized palmitoylethanolamide/polydatin on chronic pelvic pain and quality of life in endometriosis patients: An open-label pilot study 1.746
Modificazione dell'umore in gravidanza e nel post-partum: ruolo degli integratori 1.741
Successful laparoscopic management of a giant ovarian cyst 1.727
Diagnosi isteroscopica del tumore endometriale: nostra esperienza 1.711
Changes in GABAA receptor gamma2 subunit gene expression induced by long-term administration of oral contraceptives in rats 1.688
Diagnosis and management of symptoms associated with vulvovaginal atrophy: expert opinion on behalf of the Italian VVA study group 1.669
Confronto tra diagnosi isteroscopica e istologica delle patologie endometriali maligne, nostra esperienza 1.608
Contraception with estradiol valerate and dienogest: adherence to the method 1.596
CARATTERISTICHE DELLA "MESTRUAZIONE", DELLA PRESSIONE ARTERIOSA E DEI SINTOMI PSICOLOGICI IN CORSO DI SEI CICLI DI TRATTAMENTO CON IL CONTRACCETTIVO ORMONALE A BASE DI E2 1.5 MG/NOMAC 2.5 MG 1.594
Large twisted ovarian fibroma associated with Meigs' syndrome, abdominal pain and severe anemia treated by laparoscopic surgery 1.584
Observational study on the stability of the psychological status during normal pregnancy and increased blood levels of neuroactive steroids with GABA-A receptor agonist activity. 1.561
STUDIO OSSERVAZIONALE SUL CONTRACCETTIVO ORMONALE CONTENENTE ESTRADIOLO VALERATO E DIENOGEST IN FORMULAZIONE QUADRIFASICA: ACCETTABILITA', EFFETTO FAVOREVOLE SULLA COMPOSIZIONE CORPOREA E SULLO STATO PSICOLOGICO 1.538
Gamma-amino-beta-hydroxy butyric acid stimulates prolactin and growth hormone release in normal women 1.537
Osteoporosis's Menopausal Epidemiological Risk Observation (O.M.E.R.O.) study 1.513
Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptives containing cyproterone acetate or desogestrel 1.497
LE ALTERAZIONI DELLA FASE OVULATORIA 1.462
Non-hormonal strategies for managing menopausal symptoms in cancer survivors: an update 1.452
XO/XY mosaicism with non fluorescent Y chromosome: clinical, cytogenetic and endocrinological studies on a female subject 1.438
Macro-regional variation in attitudes toward and experiences of vulvar and vaginal atrophy among Italian post-menopausal women: a post hoc analysis of REVIVE survey data 1.420
Low androgenization index in elderly women and elderly men with Alzheimer's disease 1.397
Placental growth factor and placental perfusion 1.395
Efficacy of intravenous tramadol treatment for reducing pain during office diagnostic hysteroscopy 1.389
Relevant changes in nephrogenesis in Down syndrome 1.380
Effects of the dopamine antagonist veralipride on hot flushes and luteinizing hormone secretion in postmenopausal women 1.372
The oral contraceptive containing 30 microg of ethinylestradiol plus 3 mg of drospirenone is able to antagonize the increase of extracellular water occurring in healthy young women during the luteal phase of the menstrual cycle: an observational study 1.368
INDICAZIONE AL PARTO CESAREO PRESSO LA CLINICA OSTETRICA E GINECOLOGICA DI CAGLIARI: SU QUALI POSSIAMO RIDURRE IL RICORSO AL PARTO CESAREO? 1.367
Left : right side ratio of endometriotic implants in the pelvis 1.362
Soy isoflavones, inulin, calcium, and vitamin D3 in post-menopausal hot flushes: an observational study 1.346
Apparent free cortisol concentration in normal men, non-pregnant, pregnant and postmenopausal women 1.326
The screening of tubal abnormalities in the infertile couple 1.313
Pattern of bone markers during pregnancy and their changes after delivery. 1.310
Short-term variations in bone remodeling markers of an oral contraception formulation containing 3 mg of drospirenone plus 30 mu g of ethinyl estradiol: observational study in young postadolescent women 1.305
Evidence that in healthy young women, a six-cycle treatment with oral contraceptive containing 30 mcg of ethinylestradiol plus 2 mg of chlormadinone acetate reduces fat mass 1.302
Multinational, multicentre, randomised, open-label study evaluating the impact of a 91-day extended regimen combined oral contraceptive, compared with two 28-day traditional combined oral contraceptives, on haemostatic parameters in healthy women 1.292
ANALGESIA EPIDURALE E INCIDENZA DI TAGLIO CESAREO. 1.284
Placental massive perivillous fibrin deposition after a previous uncomplicated term pregnancy: report of two cases. 1.262
EZIOPATOGENESI DEI MIOMI UTERINI 1.249
B-mode and Power Doppler Ultrasound in Adnexsal Masses 1.229
Observational study on the efficacy of tibolone in counteracting early carotid atherosclerotic lesions in postmenopausal women 1.206
The effect of vulvovaginal atrophy on women’s quality of life from an Italian cohort of the EVES study 1.203
Correlazioni tra composizione corporea ed età 1.186
The treatment of polycystic ovary syndrome 1.184
The impact of COVID-19 lockdown on admission to gynecological emergency departments: Results from a multicenter Italian study 1.143
Reflections and recommendations on the COVID-19 pandemic: Should hormone therapy be discontinued? 1.101
The 12-month treatment with the oral contraceptive formulation containing dienogest (DNG) and estradiol valerate (E2V) shows beneficial effects on psychological symptoms: results from a prospective comparative study with a formulation containing ethinyl estradiol (EE) and drospirenone (DRSP) 1.097
Totale 192.371
Salva come PNG Salva come JPEG
Categoria #
all - tutte 422.274
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 422.274
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.344 0 0 0 0 0 0 0 0 0 0 0 1.344
2021/202213.719 1.339 1.099 581 1.097 1.273 1.049 1.223 678 1.119 1.172 1.516 1.573
2022/202319.530 2.034 2.185 2.190 1.436 1.536 1.748 773 3.042 1.287 981 1.548 770
2023/202425.933 1.565 1.429 1.192 1.953 2.807 4.246 4.430 1.463 1.198 1.745 2.055 1.850
2024/202541.293 4.382 6.941 5.441 4.813 2.487 4.475 3.433 302 709 6.868 561 881
2025/202639.496 795 924 2.066 1.451 922 1.163 2.292 690 25.404 1.884 1.533 372
Totale 302.552